A23V 2250/708
Vitamin c
Official title: Vitamin C
A23V2250/708 (Vitamin c) appears on 27 US grants and 48 published applications in this corpus.
Search patents in A23V- Granted patents
- 27
- Published applications
- 48
- Assignees
- 24
- Inventors
- 84
- Latest grant
- 14 Oct 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2010 | 0 | 2 |
| 2011 | 0 | 3 |
| 2012 | 0 | 0 |
| 2013 | 1 | 0 |
| 2014 | 0 | 0 |
| 2015 | 1 | 0 |
| 2016 | 0 | 2 |
| 2017 | 1 | 0 |
| 2018 | 1 | 6 |
| 2019 | 2 | 16 |
| 2020 | 5 | 6 |
| 2021 | 5 | 2 |
| 2022 | 5 | 3 |
| 2023 | 2 | 3 |
| 2024 | 3 | 2 |
| 2025 | 1 | 3 |
By publication year.
Recent patents
- Edible composition for alleviating visual fatigue14 Oct 2025US 12,440,532 B2Shanghai Lytone Biochemicals, LTD.
- Nutritional supplements22 Oct 2024US 12,121,050 B2Laminaria Group AB
- Oligosaccharide syrup having improved stability16 Jan 2024US 11,871,774 B2Samyang Corporation
- Nutraceutical gels2 Jan 2024US 11,857,593 B24Life Patents, LLC
- Deuterated caffeine and uses thereof6 Jun 2023US 11,666,073 B2Lennham Pharmaceuticals, Inc.
- Deuterated caffeine and uses thereof7 Aug 2025US 2025/0248424 A1Lennham Pharmaceuticals, Inc.
- Nutritional supplements1 May 2025US 2025/0134150 A1Laminaria Group AB
- Composition for use as a dietary supplement for the production of short-chain peptides in the digestive tract which are relevant for the appearance of the skin10 Apr 2025US 2025/0114437 A1
- Deuterated caffeine and uses thereof29 Aug 2024US 2024/0284942 A1Lannham Pharmaceuticals, Inc,
- Ethyl glucoside-containing composition and method for reducing a pungent taste attributed to ethyl glucoside7 Mar 2024US 2024/0074462 A1Suntory Holdings Limited
Most cited
By later US patents
- Composition for countering the effects of alcohol consumption5US 8,507,015 B2Lquid Innovations, LLC · 2013
- Deuterated caffeine and uses thereof4US 10,582,716 B1Lennham Pharmaceuticals, Inc. · 2020
- Deuterated caffeine and uses thereof3US 10,765,130 B1Lennham Pharmaceuticals, Inc. · 2020
- Nutritional formulations using human milk oligosaccharides for modulating inflammation2US 10,624,916 B2Abbott Laboratories · 2020
- Dietary supplement for glycemia control and diabetes prevention2US 10,757,961 B2World Pharmaceutical Technology, LLC · 2020